Breaking A New 52 Week High, Masimo Corporation (Nasdaq:MASI) Finishes At $137.05

MASI
MASI

Masimo Corporation (Nasdaq:MASI)

March 21st, 2019

With markets going up Masimo Corporation closed the day up $3.45 Thursday which equals a 2.58% increase, closing at $137.05. Furthermore it hit a new 52 week high of $137.70.

Results from 5 analysts suggest that Masimo Corporation could rise somewhat (6.38%), while Finbox has calculated (with low uncertainty) a fair value price of $107.89.

Market Sectors

The market sectors were mixed Thursday with a majority of the sectors trending up. Information Technology saw the biggest increase of the day (2.47%), while Financials saw the biggest drop (-0.30%). Information Technology has seen the biggest year-to-date gain at 18.16%.

Real Estate saw the biggest turnaround from its 5-day performance of -0.72%, as it went up 1.79%. Financials saw a turn around from its 5-day performance of -0.81% trading down -0.30%.

Sector Breakdown

  • Information Technology went up with a 2.47% change.
  • Real Estate went up with a 1.79% change.
  • Consumer Discretionary went up with a 1.32% change.
  • Consumer Staples went up with a 1.19% change.
  • Utilities went up with a 1.05% change.
  • Materials went up with a 1.04% change.
  • Industrials went up with a 0.95% change.
  • Communication Services went up with a 0.89% change.
  • Energy went up with a 0.69% change.
  • Healthcare went up with a 0.35% change.
  • Financials went down with a -0.30% change.

Masimo Corporation Info

Masimo Corporation, a medical technology company, develops, manufactures, and markets noninvasive monitoring technologies worldwide. The company offers Masimo Signal Extraction Technology (SET) pulse oximetry with measure-through-motion and low-perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry. It also provides Masimo rainbow SET platform that includes rainbow SET Pulse CO-Oximetry products that noninvasively monitor hemoglobin species, including oxygen saturation, pulse rate, perfusion index, pleth variability index, and respiration rate from the pleth; noninvasively monitor hemoglobin concentration, and carboxyhemoglobin and methemoglobin saturation; monitor arterial oxygen saturation and acoustic respiration rate; and calculates oxygen content and oxygen reserve index. In addition, the company offers SedLine brain function monitoring technology to measure the brain’s electrical activity by detecting EEG signals; capnography and gas monitoring products comprising external plug-in-and-measure capnography and gas analyzers, integrated modules, and handheld capnograph and capnometer devices; and O3 regional oximetry for tissue oxygen saturation measurement. Further, it provides Patient SafetyNet, a surveillance, remote monitoring, and clinician notification solution; MyView, a wireless presence-detection system; and connectivity devices. The company provides its products directly, as well as through distributors and original equipment manufacturers partners to hospitals, emergency medical service providers, physician offices, veterinarians, long term care facilities, and consumers. Masimo Corporation has a strategic partnership with NU Hospitals. The company was founded in 1989 and is headquartered in Irvine, California.

All amounts in USD unless otherwise indicated

MASI daily update
MASI daily update

Media Gazelle Inc (MG), a Nevada Corporation, owns and operates the online brand US Tribune News. MG does not offer financial advise, and is not a registered broker/dealer/analyst/adviser, holds no investment licenses, and may not sell, offer to sell or offer to buy any security. MG’s market updates, news are not a solicitation or recommendation to buy, sell or hold securities. MG shall not be held liable for any investment losses you may incur by using the information provided, this includes you trading the stocks mentioned on our sites. We recommend you talk to a financial adviser before trading any securities or taking any action based upon information on this site. MG does not guarantee the accuracy of the article.